Novo’s $1,000 Ozempic drug for diabetes treatment can be made for less than $5 a month, says study
Research reveals that the manufacturing cost of Ozempic is significantly lower than its selling price of $1,000 per month. The study emphasizes the excessive pricing of GLP-1 drugs like Ozempic, impacting patients' access due to affordability issues in the US market.
Disclaimer : Mytimesnow (MTN) lets you explore worldwide viral news just by analyzing social media trends. Tap read more at source for full news. The inclusion of any links does not necessarily imply any endorsement of the views expressed within them.
